 Home > Active Ingredient News > Digestive System Information > Entyvio (Vedolizumab) long-term maintenance treatment of moderate to severe active ulcerative colitis: safety and effectiveness are worthy of recognition.

Entyvio (Vedolizumab) long-term maintenance treatment of moderate to severe active ulcerative colitis: safety and effectiveness are worthy of recognition.

 Last Update: 2020-10-20
 Source: Internet
 Author: User

Tags

vedolizumab entyvio

label

adverse reaction antibiotics

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Takeda Pharmaceuticals Co., Ltd. today released the interim results of the OLE study, which assessed the long-term safety and ability of Subsulculation Maintenance Therapy in Entyvio (Vedolizumab) to treat moderate to severe active ulcerative colitis (UC).
the results of Vedolizumab's long-term safety studies are consistent with known safety when evaluating the main safety endpoints of the trial.
data were presented at the UEG Week Virtual 2020 conference.
OLE is an ongoing open-label, multi-center Phase IIIb study designed to assess the long-term safety and stability of Theentyvio (Vedolizumab) subsc skin maintenance treatment UC.
During the two-year period of maintenance, 69 per cent of UC patients had adverse events, the most common adverse reactions being disease deterioration (18 per cent), nasopharyngitis (11 per cent), upper respiratory tract infections (9 per cent) and anemia (7 per cent).
reaction at the injection site was reported in 4.5% of patients, with mild or moderate severity.
14% of patients had severe adverse events, no cases of aggressive polyetopic lewd encephalopathy, and no deaths.
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Ursodiol128-13-2 hot sale

CAS No.: 128-13-2

API Grade

$100/KG EXW

Chenodeoxycholic acid474-25-9 hot sale

CAS No.: 474-25-9

API Grade

$100/KG EXW

5-Aminosalicylic Acid cas89-57-6

CAS No.: 89-57-6

Pharmaceutical grade

$10/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.